Chartwell Investment Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-4,775
| Closed | -$280K | – | 406 |
|
|
2019
Q4 | $280K | Buy |
4,775
+199
| +4% | +$11.7K | 0.01% | 399 |
|
|
2019
Q3 | $244K | Hold |
4,576
| – | – | 0.01% | 401 |
|
|
2019
Q2 | $229K | Sell |
4,576
-14,812
| -76% | -$741K | 0.01% | 406 |
|
|
2019
Q1 | $1.01M | Sell |
19,388
-219,702
| -92% | -$11.5M | 0.03% | 387 |
|
|
2018
Q4 | $11.4M | Sell |
239,090
-22,704
| -9% | -$1.08M | 0.4% | 81 |
|
|
2018
Q3 | $13.1M | Buy |
261,794
+10,152
| +4% | +$510K | 0.39% | 81 |
|
|
2018
Q2 | $12.7M | Sell |
251,642
-82,776
| -25% | -$4.17M | 0.38% | 96 |
|
|
2018
Q1 | $16.3M | Buy |
334,418
+44,374
| +15% | +$2.17M | 0.56% | 48 |
|
|
2017
Q4 | $12.9M | Sell |
290,044
-174,728
| -38% | -$7.75M | 0.44% | 80 |
|
|
2017
Q3 | $23.6M | Sell |
464,772
-8,196
| -2% | -$416K | 0.8% | 9 |
|
|
2017
Q2 | $25.5M | Sell |
472,968
-7,728
| -2% | -$417K | 0.96% | 4 |
|
|
2017
Q1 | $25.3M | Buy |
480,696
+80,663
| +20% | +$4.25M | 0.92% | 5 |
|
|
2016
Q4 | $19.3M | Sell |
400,033
-59,200
| -13% | -$2.85M | 0.66% | 35 |
|
|
2016
Q3 | $24.8M | Buy |
459,233
+9,845
| +2% | +$531K | 0.44% | 51 |
|
|
2016
Q2 | $24.3M | Buy |
449,388
+376,804
| +519% | +$20.4M | 0.43% | 48 |
|
|
2016
Q1 | $3.68M | Buy |
72,584
+3,064
| +4% | +$155K | 0.07% | 234 |
|
|
2015
Q4 | $3.51M | Buy |
+69,520
| New | +$3.51M | 0.07% | 239 |
|
|
2014
Q3 | – | Sell |
-47,096
| Closed | -$3.15M | – | 354 |
|
|
2014
Q2 | $3.15M | Sell |
47,096
-2,480
| -5% | -$166K | 0.07% | 278 |
|
|
2014
Q1 | $3.31M | Buy |
49,576
+472
| +1% | +$31.5K | 0.07% | 271 |
|
|
2013
Q4 | $3.28M | Buy |
+49,104
| New | +$3.28M | 0.07% | 276 |
|